1. Home
  2. BCPC vs STVN Comparison

BCPC vs STVN Comparison

Compare BCPC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCPC
  • STVN
  • Stock Information
  • Founded
  • BCPC 1967
  • STVN 1949
  • Country
  • BCPC United States
  • STVN Italy
  • Employees
  • BCPC N/A
  • STVN N/A
  • Industry
  • BCPC Major Chemicals
  • STVN Containers/Packaging
  • Sector
  • BCPC Industrials
  • STVN Consumer Discretionary
  • Exchange
  • BCPC Nasdaq
  • STVN Nasdaq
  • Market Cap
  • BCPC 5.3B
  • STVN 6.6B
  • IPO Year
  • BCPC N/A
  • STVN 2021
  • Fundamental
  • Price
  • BCPC $166.70
  • STVN $22.14
  • Analyst Decision
  • BCPC Strong Buy
  • STVN Buy
  • Analyst Count
  • BCPC 1
  • STVN 6
  • Target Price
  • BCPC $180.00
  • STVN $25.08
  • AVG Volume (30 Days)
  • BCPC 141.4K
  • STVN 326.1K
  • Earning Date
  • BCPC 07-25-2025
  • STVN 05-08-2025
  • Dividend Yield
  • BCPC 0.52%
  • STVN 0.27%
  • EPS Growth
  • BCPC 17.80
  • STVN N/A
  • EPS
  • BCPC 4.17
  • STVN 0.50
  • Revenue
  • BCPC $964,544,000.00
  • STVN $1,215,562,040.00
  • Revenue This Year
  • BCPC $8.63
  • STVN $8.42
  • Revenue Next Year
  • BCPC $6.85
  • STVN $10.44
  • P/E Ratio
  • BCPC $39.98
  • STVN $44.76
  • Revenue Growth
  • BCPC 3.76
  • STVN 3.81
  • 52 Week Low
  • BCPC $145.70
  • STVN $16.56
  • 52 Week High
  • BCPC $186.03
  • STVN $25.75
  • Technical
  • Relative Strength Index (RSI)
  • BCPC 54.16
  • STVN 46.39
  • Support Level
  • BCPC $164.63
  • STVN $21.97
  • Resistance Level
  • BCPC $169.16
  • STVN $24.43
  • Average True Range (ATR)
  • BCPC 2.94
  • STVN 1.28
  • MACD
  • BCPC -0.12
  • STVN -0.21
  • Stochastic Oscillator
  • BCPC 49.55
  • STVN 7.67

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: